Skip to content
HowShorted

GT Biopharma, Inc. short interest in 2021

In 2021, GT Biopharma, Inc.'s disclosed short interest ran from 4.29% of shares outstanding on 15 Apr 2021 to 2.91% on 31 Dec 2021, a change of -1.38 percentage points. The year's high was 7.17% on 28 May 2021 and its low 2.69% on 29 Oct 2021, averaging 4.25% across 18 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.73 days on 15 Jul 2021. Full history: GT Biopharma, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for GT Biopharma, Inc. in 2021

2021 in figures

Start of year
4.29% (15 Apr 2021)
End of year
2.91% (31 Dec 2021)
Change
-1.38 pp
High
7.17% (28 May 2021)
Low
2.69% (29 Oct 2021)
Average
4.25%
Highest days to cover
7.73 (15 Jul 2021)
SEC filings marked
4

Every report in 2021

GT Biopharma, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Apr 20214.29%1.10
30 Apr 20214.93%3.2810-K filed
14 May 20215.28%2.06
28 May 20217.17%5.8410-Q filed
15 Jun 20214.63%3.41
30 Jun 20216.50%3.11
15 Jul 20215.61%7.73
30 Jul 20215.03%6.00
13 Aug 20214.96%7.49
31 Aug 20214.09%2.3710-Q filed
15 Sep 20213.89%4.03
30 Sep 20213.08%2.43
15 Oct 20212.77%3.13
29 Oct 20212.69%3.95
15 Nov 20212.73%1.7910-Q filed
30 Nov 20213.05%4.00
15 Dec 20212.89%2.42
31 Dec 20212.91%3.44

See also: GT Biopharma, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.